GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick relief and daily control.
Zydus Lifesciences Limited (Zydus), an innovation-led life-sciences company with an international presence, has launched Aerolife Mini, a next-generation pMDI enhancer marking a significant step in ...
MUMBAI, India, March 19, 2026 /PRNewswire/ -- AeroDel Technology Innovations Pvt. Ltd., a Mumbai-based respiratory medical device company, announces an exclusive licensing arrangement with Zydus ...
Severe childhood asthma remains a major challenge in low- and middle-income countries. Find out more about treatment gaps and ...
Independent Newspaper Nigeria on MSN
Asthma, allergy surge sweeps Africa as costly treatments limit access — researchers
LAGOS – Urbanisation, environmental changes, and lifestyle modifications in low- and middle-income countries are driving a sharp rise in allergy rates across Africa, while barriers to accessing ...
Indian markets closed with sharp losses on Thursday, with benchmark indices falling over 3 percent amid global risk-off ...
HLIB Research said UMediC guided for a 10% to 15% revenue growth on the back of an improved order book from the Health Ministry. PETALING JAYA: UMediC Group Bhd ’s entry into new markets in Latin ...
Through a partnership with Akron Children’s Hospital, East Liverpool City Schools were able to provide healthcare services to ...
Asthma + Lung said two thirds of people with asthma were not receiving adequate levels of care An asthma charity has called for better monitoring of the use of inhalers after the death of a ...
GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm Adherium, ...
More than 20 years after gaining FDA approval for Flovent, GSK still controlled the market in the U.S. for the asthma inhaler through a partnership with an “authorized generic” dealer, a setup that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results